Suppressing effect of the cannabinoid CB1 receptor antagonist, rimonabant, on alcohol self-administration in alcohol-preferring rats

Open Neuropsychopharmacology Journal

Volumn 2, Issue , 2009, Pages 40-44

  Maccioni, Paola ^a   Fantini, Noemi ^a   Carai, Mauro A M ^a   Gessa, Gian Luigi ^a   Colombo, Giancarlo ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; RIMONABANT;

ALCOHOL CONSUMPTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TRAINING;

EID: 77949879448     PISSN: None     EISSN: 18765238     Source Type: Journal    
DOI: 10.2174/1876523800902020040     Document Type: Article

References (40)

1. Arnone M, Maruanim J, Chaperon F, et al. Selective inhibition of sucrose and alcohol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 1997; 132: 104-106 (Pubitemid 27303746)
2. Lallemand F, Soubrié PH, De Witte PH. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin Exp Res 2001; 25: 1317-1323 (Pubitemid 32868340)
3. Serra S, Carai MAM, Brunetti G, et al. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behaviour in alcohol-preferring rats. Eur J Pharmacol 2001; 430: 369-371 (Pubitemid 33050063)
4. Poncelet M, Maruani J, Calassi R, Soubrié P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 2003; 343: 216-218 (Pubitemid 38365988)
5. Bell RL, Rodd ZA, Sable HJK, et al. Cannabinoid CB1 antagonist reduces alcohol intake during acquisition, maintenance, and relapse in inbred alcohol preferring (IP) rats. Abstract Viewer/It Planner. Washington DC: Society for Neuroscience 2004; Program No. 489-496
6. Colombo G, Agabio R, Fà M, et al. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR 141716. Alcohol Alcohol 1998; 33: 126-130 (Pubitemid 28161888)
7. Colombo G, Orrù A, Lai P, et al. The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence. Mol Neurobiol 2007; 36: 102-112 (Pubitemid 351360349)
8. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. USA 2003; 100: 1393-1398
9. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 2005; 164: 206-213 (Pubitemid 41337875)
10. Kelaï S, Hanoun N, Aufrère G, Beaugé F, Hamon M, Lanfumey L. Cannabinoid-serotonin interactions in alcohol-preferring vs alcohol-avoiding mice. J Neurochem 2006; 99: 308-320
11. Dyr W, Ligieza J, Kostowski W. The effect of cannabinoid CB1 receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol 2008; 42: 509-512
12. Vinod KY, Yalamanchili R, Thanos PK, et al. Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse 2008; 62: 574-581
13. Lallemand F, Soubrié P, De Witte P. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals. Alcohol Alcohol 2004; 39: 486-492 (Pubitemid 39534529)
14. Serra S, Brunetti G, Pani M, et al. Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 2002; 443: 95-97 (Pubitemid 34603602)
15. López-Moreno JA, González-Cuevas G, Navarro M. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol. Neurobiol Dis 2007; 25: 274-283 (Pubitemid 46124008)
16. Freedland CS, Sharpe AL, Samson HH, Porrino LJ. Effects of SR 1417161A on alcohol and sucrose self-administration. Alcohol Clin Exp Res 2001; 25: 277-282
17. Cippitelli A, Bilbao A, Hansson AC, et al. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 2005; 21: 2243-2251 (Pubitemid 40695249)
18. Rodd ZA, Bell RL, Pommer TJ, et al. The CB1 antagonist SR141716 transiently reduces operant ethanol self-administration during relapse and maintenance, and inhibits alcohol seeking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 2005; 29: 19A.
19. Economidou D, Mattioli L, Cifani C, et al. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology 2006; 183: 394-403. (Pubitemid 41721140)
20. Economidou D, Mattioli L, Ubaldi M, et al. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to δ9-tetrahydrocannabinol. Toxicol Appl Pharmacol 2007; 223: 73-85. (Pubitemid 47211268)
21. Pavon FJ, Bilbao A, Hernández-Folgado L, et al. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole - LH 21. Neuropharmacology 2006; 51: 358-366
22. Hansson AC, Bermudez-Silva FJ, Malinen H, et al. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 2007; 32: 117-126 (Pubitemid 44967790)
23. Malinen H, Hyytiä P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcohol Clin Exp Res 2008; 32: 1976-1983
24. Ginsburg BC, Lamb RJ. Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison. Behav Pharmacol 2006; 17: 249-257
25. Gallate JE, McGregor IS. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 1999; 142: 302-308
26. Colombo G, Vacca G, Serra S, Carai MAM, Gessa GL. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur J Pharmacol 2004; 498: 119-123 (Pubitemid 39208070)
27. Rinaldi-Carmona M, Barth F, Congy C, et al. SR147778 [5-(4-bromophenyl)- 1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 2004; 310: 905-914
28. Gessa GL, Serra S, Vacca G, Carai MAM, Colombo G. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 2005; 40: 46-53.
29. Lallemand F, De Witte P. SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats. Alcohol 2006; 39: 125-134 (Pubitemid 44791806)
30. Ren K, Bristow LJ, Fong T, Lorrain DS, Morse AC. The cannabinoid CB1 receptor inverse agonist AM251 attenuates alcohol self-administration and the alcohol deprivation effect. Abstract Viewer/It Planner. Washington DC: Society for Neuroscience 2004; Program No. 117-211
31. Colombo G, Lobina C, Carai MAM, Gessa GL. Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non preferring (sNP) rats. Addict Biol 2006; 11: 324-338 (Pubitemid 46696906)
32. B receptor, GS39783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology 2007; 193: 171-178
33. Rubio G, Ponce G, Rodriguez-Jimenez R, Jimenez-Arriero MA, Hoenicka J, Palomo T. Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol 2005; 40: 227-233
34. De Vry J, Schreiber R, Eckel G, Jentzsch KR. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur J Pharmacol 2004; 483: 55-63. (Pubitemid 38056604)
35. Verty AN, Allen AM, Oldfield BJ. The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity 2009; 17: 254-261
36. Weiss F, Porrino LJ. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 2002; 22: 3332-3337 (Pubitemid 37465737)
37. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 2002; 13: 451-463
38. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 2003; 84: 698-704. (Pubitemid 36176928)
39. Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology 2005; 183: 368-377 (Pubitemid 41660423)
40. Soyka M, Koller G, Schmidt P, et al. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 2008; 28: 317-324